Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

Abroad (travel likely)Recruiting

Conditions

Antiphospholipid Syndrome (APS) · Venous Thrombosis (Disorder) · Thrombophilia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hospital Universitario Infanta Leonor, Madrid, Madrid, Spain
Contact: Study coordinator (Anabel Franco-Moreno, MD, PhD) · afranco278@hotmail.com · 686102661
Hospital Universitario Infanta Sofía, Madrid, Madrid, Spain
Contact: Study coordinator (Isabel Perales Fraile, MD) · isabelperalesf@gmail.com

Study leads

Anabel Franco-Moreno, MD, PhD
Principal Investigator
Sociedad Española De Medicina Interna

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

Antiphospholipid Syndrome · Thrombosis · Anticoagulants Causing Adverse Effects in Therapeutic Use

Abroad (travel likely)Recruiting

Nancy, France

Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)

Antiphospholipid Syndrome (APS)

Abroad (travel likely)RecruitingPHASE2

Athens, Greece

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

Systemic Lupus Erythematosus · Antiphospholipid Syndrome

Abroad (travel likely)Recruiting

Chicago, United States · Chicago, United States

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Antiphospholipid Syndrome (APS) · Bullous Pemphigoid (BP) · Behçet's Syndrome (BS)

Abroad (travel likely)RecruitingPHASE1

Orange, United States · Baltimore, United States